Akebia Therapeutics Inc (NASDAQ:AKBA)
| 0.3866 Delayed Data As of Aug 09 |  -0.0184 / -4.54%Today’s Change | 0.30 Today|||52-Week Range 3.35 | -82.89% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -60.7M | -135.7M | -76.9M | -143.6M | |
| Depreciation | 96.0K | 296.0K | 617.0K | 2.4M | ||
| Total Other Cash Flow | 5.3M | 6.6M | 12.9M | 36.0M | ||
| Funds From Operations | -55.3M | -128.8M | -63.4M | -133.5M | ||
| Funds From/For Other Operating Expenses | -2.9M | -186.7M | -7.2M | -36.0M | ||
| Net Cash Flow - Operating Activities | -52.4M | 57.9M | -56.2M | -97.5M | ||
| Investing | Increase In Investments | -77.2M | -147.0M | -330.6M | -224.2M | |
| Decrease In Investments | 63.9M | 162.4M | 155.0M | 256.3M | ||
| Capital Expenditures | -414.0K | -2.7M | -1.6M | -1.6M | ||
| Fixed Asset Disposal | -- | -- | -- | 6.1M | ||
| Net Cash Flow Investing | -13.7M | 12.7M | -177.3M | 36.6M | ||
| Financing | Short Term Borrowings | -- | -- | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | -- | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | -7.0K | -20.0K | -5.0K | -19.0K | ||
| Net Proceeds Stock Sale | 83.1M | 67.0M | 116.2M | 96.6M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | -- | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | -- | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 83.1M | 66.9M | 116.2M | 96.6M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 17.0M | 137.6M | -117.2M | 35.7M | ||
